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Cholesterol homeostasis is maintained through the regulation of three metabolic pathways. Two pathways function in the supply of cholesterol to cells. These include an endogenous biosynthetic pathway in which cholesterol is synthesized from acetate precursors and an exogenous pathway in which the low-density lipoprotein (LDL) receptor internalizes cholesterol-carrying lipoprotein particles from the blood (20) . A third pathway functions in the catabolism of cholesterol and involves its conversion to bile acids. Improper regulation of this pathway has pathological implications because the major pathway for the catabolism and excretion of cholesterol in mammals is the formation of bile acids. The rate of elimination of cholesterol is a critical factor in diseases such as atherosclerosis, gallstone disease, and some lipid storage diseases (5, 11, 13) . The initial and rate-limiting step in this pathway is the hydroxylation of cholesterol at position 7 and is catalyzed by the enzyme cholesterol 7a-hydroxylase (7oa-hydroxylase) (cholesterol 7a-monooxygenase; EC 1.14.13.17), a microsomal cytochrome P450 (35) . This enzyme is subject to a feedback control, whereby high levels of bile acids returning to the liver via the enterohepatic circulation suppress its activity. Cholesterol, the substrate of the enzyme, exerts a positive control.
The rat and human 7ot-hydroxylase cDNAs have been isolated by several groups (7, 26, 30, 37, 38) . The availability of these molecular probes has facilitated studies directed towards understanding the molecular mechanisms that regulate bile acid synthesis. For example, Jelinek et al. have shown that the 7a-hydroxylase gene is expressed only in liver (26) , as expected, since bile acids are synthesized only in that organ (35) . Also, the activity of 7a-hydroxylase exhibits a circadian rhythm in rats, with a maximum at midnight and a minimum during the daytime (35) . This diurnal variation of enzyme activity is due to changes in the protein and mRNA levels (39) and appears to be due, at least in part, to variable levels of glucocorticoids (32) . Specific dietary manipulations have been shown to alter 7ot-hydroxylase protein levels, enzyme activity, and mRNA levels. Cholestyramine, a resin that binds bile acids, thus reducing their levels in the liver, and cholesterol feeding of rats effectively up-regulates 7a-hydroxylase protein levels and enzyme activity by increasing the amount of 7a-hydroxylase mRNA about twofold (26, 30, 39, 53) . In addition, 7a-hydroxylase mRNA and protein levels decrease (5-to 10-fold) when rats are fed bile acids (26) .
Different approaches have been used to study the molecular mechanism(s) involved in the bile acid-and cholesterol-mediated regulation of the 7a-hydroxylase gene. It has been proposed that transcriptional regulation plays a role by analogy with other systems involved in cholesterol homeostasis (26, 33, 46, 52) . Studies in tissue culture systems have been difficult because of the lack of appropriate cell lines with which transcriptional regulation could be studied. Recently, chimeric genes containing fragments of the 5'-flanking region of the human 7a-hydroxylase gene have been expressed in HepG2 cells, but it is not known whether they are regulated by cholesterol and/or bile acids (33) . Bile acid-mediated regulation of 7a-hydroxylase mRNA and transcription has been shown in isolated primary rat hepatocytes (24, 52) , although the extent of regulation (2-fold) differs from the regulation of mRNA levels in the entire animal (5-to 10-fold) (26, 53) . It has been suggested that posttranscriptional control plays a major part in that regulation as shown by nuclear run-on assays (52) and by the discrepancy between the bile acid-mediated regulation of 7a-hydroxylase mRNA in hepatocytes in culture (ninefold) compared with the twofold decrease in transcription as quantified by run-on or by the suppression of a chloramphenicol acetyltransferase (CAT) activity directed by promoter constructs containing up to 3.6 kb of 7a-hydroxylase upstream sequences.
Two methods are currently available to test for regulated expression of the transcription of cloned genes. One approach is to introduce a purified gene into cells in culture by transfection. Regulation is measured by the differential expression of a gene in an appropriate cell line upon addition of the effector. Major advantages of this method are the relative ease in testing multiple genes or altered gene constructs and the speed of the assay. It is impractical, however, when cell-specific functions ought to be studied, since cells in culture tend to express all transfected eukaryotic genes at a low basal level regardless of cell specificity. Similarly, conditions such as cholesterol homeostasis require whole animal models to study the complex interaction of whole organ systems. The other approach of choice is to introduce cloned genes into all cells of an animal by microinjection into fertilized eggs to create transgenic animals (41) . A major advantage of this method is the ability to assay for expression in many tissues of an animal. It also provides a more physiological system for studying tissue-specific and developmentally regulated genetic elements (42) . The limitation of transgenic technologies is the length of time required for the production and generation of several lines of transgenic animals containing a single gene construct.
In the present study, we used both approaches to investigate the regulation of the expression of the 7a-hydroxylase gene. First, we used a conditionally transformed hepatocyte cell line, H2.35 (56) , to transfect chimeric genes containing different portions of the 5'-flanking region of the rat 7ot-hydroxylase gene. This system allowed us to localize a liver-specific enhancer located 7 kb upstream of the transcriptional initiation site. We have also shown that LDL mediates transcriptional activation of chimeric genes containing either the 7ot-hydroxylase or the albumin enhancer in front of the 7ot-hydroxylase promoter in differentiated liver cells, to the same extent as the in vivo cholesterol-mediated regulation of 7a.-hydroxylase mRNA. However, bile acids only partially (twofold) regulated rat 7a-hydroxylase promoter activity in that tissue culture system. Thus, we used transgenic mice to study that regulation, and we showed that mice harboring a chimeric gene carrying the 7ao-hydroxylase 5'-flanking region with the albumin enhancer expressed the reporter gene whereas a fusion gene containing the same 7a-hydroxylase proximal promoter but without enhancer did not show expression. This analysis supported our tissue culture experiments which indicate that either the 7a-hydroxylase enhancer or the albumin enhancer is necessary for transcription of the 7o-hydroxylase promoter (see Fig. 1 , 2, and 6). More (48) . DNA probes were 32p labeled by the method of Church and Gilbert (9) . DNA sequencing was done by the dideoxy chain termination method of Sanger et al. (49) with either the M13 universal sequencing primer or specific oligonucleotides, after subcloning into bacteriophage M13 vectors (48) . In certain GC-rich regions, 20% formamide was used in the sequencing gels (12) . Both strands were sequenced at least once. Human LDL and lipoprotein-deficient fetal calf serum were prepared by ultracentrifugation (18) . Protein content was measured by the method of Bradford (2) .
Cloning of the rat 7a-hydroxylase gene. Rat liver DNA was prepared as described elsewhere (48) . After partial Sau3AI digestion, fragments ranging in size between 15 and 25 kb were purified and ligated to the BamHI arms of the cloning vector XGEM-11. After in vitro packaging of the recombinant molecules into infectious phage particles, clones were screened for inserts containing 7ot-hydroxylase sequences by in situ hybridization (48) using as a probe an oligonucleotide complementary to nucleotides +86 to + 125, which corresponds to the beginning of the coding region of the published rat 7a-hydroxylase cDNA sequence (37) . Two clones, XR7a-1 and XR7oa-2, were identified out of 3 x 105 recombinants. For more detailed analysis of X clones, subgenomic fragments were generated by digestion with EcoRI, BamHI, and PstI and subcloned into plasmid vectors. The transcriptional initiation site was determined by primer extension and S1 nuclease analysis and coincided, essentially, with the position described by Jelinek et al. (27) .
Plasmid constructions. Plasmid pR7oaCAT-1 was constructed by insertion of a 4-kb PstI fragment, excised from XR7ot-1, which spans from 1.6 For each experiment, 100-mm-diameter plastic dishes were seeded on day 0 at 106 cells per dish in 8 ml of basal medium and incubated at the permissive temperature for SV40, 33°C (dedifferentiating conditions). For differentiating conditions, 100-mm-diameter dishes containing 4 ml of a 1.35-mg/ml gel of rat type I collagen prepared exactly as described by Zaret et al. (56) were seeded with 2 x 106 cells per dish in 8 ml of basal medium supplemented with 10% fetal calf serum. After the cells on collagen were cultured at the nonpermissive temperature (39°C) for 3 to 5 h, the medium was replaced by serum-free medium (56) and maintained at 39°C. On day 2, cells were refed with either basal medium or serum-free medium and harvested by scraping (plastic dishes) or by a brief collagenase digestion (collagen plates) on day 3. Cells were lysed by three cycles of freeze-thawing, and ,-galactosidase activity was determined as described by Sambrook et al. (48) with o-nitrophenyl-fi-D-galactopyranoside as a substrate. One unit of ,-galactosidase activity is defined as the amount of enzyme that transforms 1 ,umol of substrate per min at 37°C. CAT activities were measured by the method of Gorman et al. (21) , after the cell extracts were incubated at 65°C for 5 min. One unit of CAT activity is defined as the amount of enzyme which transforms 1 nmol of chloramphenicol into its acetylated products per min at 37°C. All assays were linear regarding time of incubation and concentration of protein.
DNA preparation for microinjection and generation of transgenic mice. For microinjection, the pR7aCAT-3 fusion gene (see Fig. 5 ) was prepared by PstI-BamHI digestion of pR7aCAT-3 (3.4 kb). The AE-7aGal-3 fusion gene (7.8 kb) (see Fig. 5 ) was prepared by BamHI complete digestion and SphI partial digestion of pAE-7aGal-3. DNA fragments were 14 days, (iii) normal diet supplemented with 5% (wt/wt) colestipol for 5 days, (iv) normal diet supplemented with 0.5% (wt/wt) cholic acid for 5 days, or (v) normal diet supplemented with 0.5% (wt/wt) chenodeoxycholic acid for 5 days. Animals were killed between the 6th and 8th of the dark period.
Preparation of tissue extracts and assay of ,I-galactosidase activity. Mouse tissues (0.5 g) were homogenized in a Dounce homogenizer on ice, with 5 ml of 40 mM Tris-HCl (pH 7.4)-i mM EDTA-500 mM sucrose-150 mM NaCl-10 mM dithiothreitol. The lysates were cleared by centrifugation at 10,000 x g for 30 min at 4°C. The soluble fraction was purified by ultracentrifugation at 100,000 x g for 90 min at 4°C and used to quantify P-galactosidase or CAT activity.
RNA purification and analysis. Total cellular RNA was isolated from tissue-cultured cells by guanidinium thiocyanate extraction followed by centrifugation through a cesium chloride cushion (8) . Primer extension analysis of Neo mRNA was performed with 15 fmol of a 40-nucleotide synthetic DNA primer complementary to nucleotides +261 to +300 of Neo RNA (1) . To initiate primer extension, 100 U of Moloney murine leukemia virus reverse transcriptase was added to the mixture and incubated for 1 h at 37°C in the presence of deoxynucleotides as described elsewhere (15) . Si nuclease analysis of the 5' end of the 7o-hydroxylase-CAT mRNA was performed essentially as described elsewhere (15) , except that the annealing temperature was 44°C, by using a single-stranded probe that spans from position -39 in the 7a-hydroxylase 5'-flanking region to the EcoRI site within the CAT coding region.
Total RNA was purified from mouse liver by guanidinium thiocyanate homogenization followed by centrifugation through a cesium chloride cushion (8) Figure 1 shows the 5'-flanking region of the rat 7o--hydroxylase gene and the structures of five 7ox-hydroxylase-CAT chimeric genes which were used to localize DNA sequences necessary for the transcription of the 7cx-hydroxylase gene in a liver-specific manner. Nucleotide + 1 corresponds to the transcription initiation site as defined by primer extension and S1 nuclease analysis of the rat mRNA (data not shown) and differs by 1 nucleotide from the site described by Jelinek and Russell (27) . Five chimeric genes were created by placing different parts of the rat 7a-hydroxylase 5'-flanking region in front of the coding region of the CAT gene. As a recipient cell line, we used a temperature-sensitive, SV40-transformed mouse hepatocyte cell line, H2.35 (56) , that has been shown to be extremely useful in the study of liver-specific functions. When H2.35 cells are cultured under the dedifferentiating conditions (see Materials and Methods), the cells assume a flat structure and transcribe liver-specific genes such as albumin at very low rates. When cultured at the differentiating conditions, the cells exhibit a cuboidal structure, and the transcription of a subset of liver-specific genes is increased selectively (31, 56) .
As shown in Fig. 1 tions was observed when the enhancer was placed in the same orientation as the endogenous gene (data not shown).
To determine whether the increase in CAT activity, upon hepatocyte differentiation, is a reflection of the amount of CAT mRNA and whether the initiation site used in the p7acE-R7aCAT-5-transfected cells corresponded to the initiation site used by the endogenous rat 7oa-hydroxylase mRNA, we performed Si nuclease analysis with RNAs isolated from those cells grown under both conditions. As a probe, we used a single-stranded DNA fragment that encompasses the transcriptional initiation site, and as a control, we quantified Neo mRNA by the primer extension technique. Figure 2B shows that the amount of CAT mRNA increased approximately threefold upon differentiation (lanes 4 and 5), and the length of the protected fragments indicated that the hybrid mRNA was initiated at the appropriate position.
Nucleotide sequence of the 7a-hydroxylase gene enhancer. Figure 3A shows the nucleotide sequence of the 7oa-hydroxylase enhancer region (-7454 (Fig. 3A) . Footprints FP II, FP IV, and FP VII were also detectable with kidney nuclear extract at least on one strand, although the levels of protection were lower. On the other hand, four regions corresponding to FP I, FP III, FP V, and FP VI were protected only with liver extract on both strands. Additionally, several hypersensitive sites (indicated by asterisks on the DNA sequence in Fig. 3A ) were also observed near or within the protected sites. Figure 3B shows a schematic summary of the nuclear protein binding sites in the 7a-hydroxylase enhancer. The sequence homologies between the sites protected by liver nuclear extract but not by kidney extract (FP I, FP V, and FP VI) and known liver-specific factor-binding sites are also illustrated. The FP III site showed no homology with known binding sites. Fig. 4B demonstrate that the albumin enhancer stimulated transcription of the 7ot-hydroxylase promoter (fourto fivefold) in differentiated H2.35 cells compared with dedifferentiated cells. This activation was similar to the one by the 7ct-hydroxylase enhancer in the chimeric gene p7aE-R7aCAT-5 ( Fig. 2 and 4A ). More importantly, when cells transfected with either one of these chimeric genes were cultured in the presence of increasing concentrations of human LDL, CAT activity rose between 2-and 2.5-fold in differentiated cells. In dedifferentiated cells lower activation, if any, was shown, suggesting that the factor(s) involved in that process is probably expressed at higher levels in differentiated H2.35 cells.
Incubation of those cell lines, H2.35 transfected with p7aE-R7oaCAT-5 or pAE-R7aCAT-5 or H2.35 transfected with pAER7aGal-3 (see Materials and Methods and below) with bile acids showed only 2-fold regulation, at best, of the transcription of the rat 7a-hydroxylase gene under all the conditions tested (28), which is far from the 5-to 10-fold regulation in vivo.
Expression of albumin enhancer-7oL-hydroxylase promoterlacZ fusion gene in transgenic mice mimics the cholesterol and bile acid-mediated regulation of the 7ox-hydroxylase gene. The lack of quantitative bile acid-mediated regulation of the expression of 7a-hydroxylase promoter-CAT fusion genes in the tissue culture system explained above could be due to the fact that liver cells in culture often do not reproduce functions observed in vivo (56), or, as it has been suggested, posttranscriptional control plays a major part in that regulation (52, 55) . To address these questions, we decided to use transgenic mice. Two fusion genes (Fig. 5) injected in mouse embryos and implanted in foster mothers. R7otCAT-3 contains the 7a-hydroxylase 5'-flanking region in front of the CAT gene. AE-R7utGal-3 contains the mouse albumin enhancer in front of the 7ot-hydroxylase 5'-flanking region and the lacZ gene. Table 1 is a summary of the mice born as a result of those experiments. Of 47 mice screened for the presence of R7oaCAT-3, 8 were positive, and they contained one to five copies of the transgene integrated into their genome. Expression experiments were performed with F1 mice generated from each founder after the mice were fed a diet containing 5% colestipol (a diet that increases 7ot-hydroxylase mRNA [26] ). We used nontransgenic mice from the same litters as controls. No CAT activity was detected in any of those mice.
Of 52 mice born as a result of the injection of AE-7otGal-3 DNA, 16 contained the transgene, and the number of integrated copies ranged from 0.6 (presumably a mosaic mouse for the transgene) to 7. Six of these transgenic founders were fed a diet containing 5% colestipol, killed, and tested for expression of 3-galactosidase activity in liver extracts. Two of these founders (FO-2 and FO-3) showed expression of the reporter gene. The remaining founders were mated, and F1 mice were tested for expression as above. One mouse line (line 1) showed expression and was used for subsequent regulatory experiments. The proportion of founder mice expressing the transgene (1 in 5) can be considered average (42) . To study whether the expression of the reporter gene in line 1 mice was restricted to the liver, as is the case for the endogenous rat 7a-hydroxylase gene (26) , protein extracts were prepared from the livers, brains, heart, kidneys, and lungs of animals fed a regular diet. As shown in Fig. 6 , ,3-galactosidase activity was clearly detectable in the liver, very low in the heart, and undetectable in brain, kidney, and lung extracts. Curiously, liver expression in males was fourfold higher than in females (see Discussion).
The regulation of the expression of the albumin enhancer- conditions (see Discussion). Cholesterol feeding elevated P-galactosidase activity 2.5-fold in males (P s 0.005) and 2-fold in females (P c 0.025), compared with mice fed a normal diet. This correlates well with results in our tissue culture system (Fig. 4) . Similar induction was observed by colestipol feeding of male (2.2-fold; P s 0.05) or female (2.7-fold; P c 0.025) mice, compared with mice fed a normal diet. Cholic acid feeding, on the other hand, reduced ,B-galactosidase activity in both males (2.9-fold; P c 0.05) and females (2.4-fold; P c 0.005). Chenodeoxycholic acid feeding also reduced f-galactosidase activity in both males (4.3-fold; P c 0.025) and females. Most significantly, in males the level of 13-galactosidase activity in colestipol-fed mice (which corresponds to the lowest level of bile acids in the liver) was 6.5-fold (P c 0.005) higher than in cholic acid-fed mice and 9.5-fold (P s 0.005) higher than in chenodeoxycholic acid-fed mice. Likewise, female colestipol-fed mice showed 6.5-fold (P c 0.005) higher 3-galactosidase activity than cholic acid-fed mice and 4.6-fold (P c 0.05) higher than chenodeoxycholic acid-fed mice.
To confirm that those changes in 3-galactosidase activity were a reflection of variations in the level of 3-galactosidase mRNA and to determine whether expression of the endogenous 7ot-hydroxylase mRNA was similarly regulated, we quantified ,B-galactosidase mRNA and 7a-hydroxylase mRNA in poly(A)+ RNA pools prepared from equal amounts of total RNA from each mouse by slot blot analysis (Fig. 8) . To normalize the amount of loaded RNA, we also quantified albumin mRNA. We used RNA from nontransgenic mice from the same litters as a negative control. Three single-stranded probes corresponding to the three mRNAs were used as described in Materials and Methods.
As indicated in Fig. 8, , B-galactosidase mRNA levels showed a pattern of induction by cholesterol and colestipol, and of suppression by cholic acid, similar to the enzymatic activity. The level of 3-galactosidase mRNA in males was also higher than that in females under all the dietary conditions. Regulation of 7a-hydroxylase mRNA was very similar, with the exception that no difference in the level of 7ot-hydroxylase mRNA was observed between males and females under any dietary condition. With these assay conditions, the 7ot-hydroxylase mRNA in females fed colestipol showed a sixfold increase with respect to normal females (Fig. 8A) , in disagreement with the regulation observed for the P-galactosidase activity and mRNA. However, when the 7oa-hydroxylase mRNA was quantified in the individual total RNA samples rather than in the pooled poly(A)+ RNAs, a twofold induction was observed (Fig. 8B) , in agreement with the 3-galactosidase activity and endogenous 7ot-hydroxylase mRNA.
DISCUSSION
It is common for liver-specific genes not to be expressed and/or regulated in tissue culture systems in a manner similar to that of the entire animal (56) . Also, conditions such as tissue-specific expression and cholesterol homeostasis require whole animal models to study the complex interactions of whole organ systems. In this study we have used two experimental approaches to study the mechanisms by which cholesterol and bile acids regulate expression of the 7oa-hydroxylase gene. First, we used a mouse hepatocyte-derived cell line, H2.35 , that can be propagated in a dedifferentiated state and then induced to the differentiated state at will (56) . The biological significance of this induction is emphasized by the enhanced transcription of a number of liver-specific genes, such as albumin and several liver-specific trans-acting factors (25, 31, 56, 57) , but not of genes encoding actin or rRNA (56) . Using this system, we have localized a liver-specific enhancer located 7 kb upstream of the transcriptional initiation site of the rat 7a-hydroxylase gene. We also showed that LDL mediates transcriptional activation of chimeric genes, containing either the 7a-hydroxylase or the albumin enhancer in front of the 7a-hydroxylase proximal promoter, to the same extent as the in vivo cholesterol-mediated regulation of 7oa-hydroxylase mRNA. However, in that tissue culture system bile acids only partially (twofold, at best) regulated rat 7ot-hydroxylase promoter activity. These limitations persuaded us to use transgenic mice to study the molecular mechanisms involved in the regulation of 7ot-hydroxylase expression. Using that approach, in this article we demonstrate that the promoter region of the rat 7ce-hydroxylase gene mediates the regulation of its transcription by bile acids and cholesterol. This regulation is quantitatively similar to that of the endogenous mouse 7a-hydroxylase gene and of the rat 7a-hydroxylase gene (7, 26, 53) , indicating that posttranscriptional modification does not play a major role, if any.
Several lines of evidence have led us to conclude the existence of a liver-specific enhancer, 7 kb upstream from the transcriptional initiation site, in the 7ot-hydroxylase gene. First, cells transfected with pR7aCAT-9, the construct containing the longest 7at-hydroxylase 5'-flanking region, has fourfold higher CAT activity under dedifferentiating conditions than cells transfected with pR7otCAT-8, which lacks the 1.2-kb Xba I fragment from the far 5'-flanking region. All other 5' deletion mutants studied showed levels of expression similar to that of pR7aCAT-8 (Fig. 1) . More importantly, when transfected H2.35 cells were induced to differentiate to hepatocyte-like cells, only pR7otCAT-9 showed higher expression (fourfold), presumably due to an increase in the rate of transcription. This was quantitatively similar to the induction of albumin transcription in the same cells (56) . Third, cells transfected with an internally deleted mutant, p7caE-R7aCAT-5, that places the putative enhancer in front of the 342 bp of proximal promoter showed levels of increased expression upon differentiation that were similar to that for pR7oaCAT-9 (Fig. 2) mRNA by SI nuclease techniques confirmed that the induction upon differentiation was due to an increase in the amount of 7ox-hydroxylase-CAT mRNA, and this mRNA was initiated at the same place as the endogenous rat 7ox-hydroxylase transcription initiation site (Fig. 2) . Another line of evidence that supports our finding of a liver-specific enhancer in the rat 7ox-hydroxylase gene derived from the DNA sequence and footprint analysis (Fig. 3 and data not shown) of the enhancer region and from the DNA sequence homologies found with the recognition sequences of a liver-specific trans-acting factor HNF-3 (Fig. 3B) . Four regions within the 7ox-hydroxylase enhancer (FP I, III, V, and VI) were protected only by liver nuclear extracts (Fig. 3) . The cluster of binding sites in the 7ot-hydroxylase enhancer resembles a similar cluster in the mouse albumin enhancer (31) and is a common characteristic of gene enhancers. Computer analysis of a data base containing the recognition sequences for liver-specific transcription factors revealed a 100% homology with an octanucleotide found in FP VI (-6405 (Fig. 4B) , which occurs at the eH site of mouse albumin enhancer (25, 31) and other liver-specific genes (17, 22, 34, 36, 50) . Competition gel shift experiments also suggested that the same or homologous factor binds to the eH site of the albumin enhancer and to the FP VI site of the 7ot-hydroxylase enhancer (data not shown). The final evidence supporting the existence of a liver-specific enhancer in the rat 7ox-hydroxylase gene comes from the studies with the albumin enhancer. We have demonstrated that the 7o-hydroxylase enhancer region can be functionally substituted by another liver-specific enhancer, the mouse albumin enhancer (Fig. 4) . This enhancer is essential for maximal expression of the albumin promoter in differentiated H2.35 cells (56, 57) and in transgenic mice (43) . Both basal activity and induction of the expression upon cell differentiation from chimeric genes that contain the 7oa-hydroxylase were equivalent to those from the genes containing the mouse albumin enhancer (Fig. 4) . It has been suggested that the albumin enhancer may require its own promoter, because it did not function with the growth hormone promoter in transgenic mice (43) . Here, however, we demonstrate that the albumin enhancer can, in fact, activate a heterologous promoter both in tissue culture cells (Fig. 4) and in transgenic mice (Fig. 5 to 8 and Table 1 ). This finding underlies the similarities between both enhancers. First, the trans-acting factor(s) that binds to both enhancers seems to be similar according to (Fig. 4) . The concentrations of LDL used (25 to 150 ,ug/ml) are well below the average plasma LDL levels both in humans (approximately 1, 200 pug/ml) and in other mammals (approximately 320 ,ug/ml) (19) .
Considering that the concentration of LDL in the interstitial fluid of humans is on the order of 10% of that in plasma, the LDL concentrations that we used are well below what can be considered physiological (19) . In the absence of either one of these enhancers, regulation could not be observed (28) , suggesting that interactions between the 7a-hydroxylase or albumin enhancers with the 7a-hydroxylase promoter are necessary for LDL-mediated regulation of 7a-hydroxylase transcription. This idea is in agreement with our observations that a common element(s) may be present in both enhancers. An alternative explanation could be that liver-specific activation, induced by either enhancer, is essential for LDL-mediated induction of 7ot-hydroxylase transcription. This regulation in our tissue culture system mimics the cholesterol-mediated induction of 7a-hydroxylase expression in rat liver (26, 30) . Although we cannot rule out that components of LDL other than cholesterol might be the regulatory factor, the fact that the same level of regulation has been observed in the entire animal upon cholesterol feeding suggests that the effector is cholesterol. 25-Hydroxy cholesterol, the most potent sterol that downregulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase and LDL receptor transcription in tissue culture cells (3, 4) , failed to show any effect on 7oa-hydroxylase gene expression in our tissue culture system, suggesting that the active sterol that up-regulates 7a-hydroxylase transcription is different from the sterol that down-regulates those two other genes. This is in agreement with the lack of significant homology between the sterol regulatory elements in the promoter region of those genes (3, 40) and the 7a-hydroxylase promoter, which suggests that the trans-acting factor(s) involved in the cholesterolmediated induction of 7ax-hydroxylase transcription is different from the factor(s) involved in the suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and LDL receptor transcription. The LDL-mediated regulation was observed only in differentiated H2.35 cells, suggesting that the factor(s) involved in that process is expressed specifically in differentiated hepatocytes.
Since we could not quantitatively reproduce the bile acidmediated regulation in our tissue culture system, we chose to address that question by using transgenic mice. We introduced two 7a-hydroxylase 5'-flanking region-reporter fusion genes (Fig. 5 ) containing 1.6 kb of the 5'-flanking region and 59 nucleotides of the 5'-untranslated region of the rat 7a-hydroxylase gene into the mouse genome. We used either the bacterial CAT gene (R7aoCAT-3) or the lacZ gene (AER7oxGal-3) as a reporter. AE-R7aGal-3 also contained the mouse albumin enhancer upstream of the 7ot-hydroxylase 5'-flanking region. The mouse albumin enhancer was chosen because it has been proven to be highly active in transgenic mice (43) and it was at least as active as the 7a-hydroxylase enhancer in tissue culture (Fig. 1, 2, and 4) . The use of two different reporter genes was circumstantial, and both genes have been successfully used as reporters to study many different promoters in transgenic mice (42, 44 (Fig. 1, 2 , and 4).
Second, our results indicate that the cholesterol and bile acid-mediated regulation of 7a-hydroxylase expression is transcriptional and most, if not all, of the regulation can be accounted for by that mechanism. This is deduced from a direct comparison of the extent of regulation of ,B-galactosidase activity (Fig. 7) and mRNA ( Fig. 8) and endogenous 7a-hydroxylase mRNA levels, from both rats (7, 26, 53 ) and mice ( Fig. 8) under the different dietary conditions tested. Thus, the regulation between colestipol-induced mice and cholic-or chenodeoxycholic acid-suppressed mice is 5-to 9.5-fold for ,-galactosidase activity and 12-fold for 3-galactosidase mRNA, compared with 13-fold for the endogenous 7a-hydroxylase mRNA.
A third insight derived from these studies is that the DNA elements that mediate both the cholesterol regulation and the bile acid regulation of 7at-hydroxylase transcription are located in the 5'-flanking region of the gene. Since expression of the AE-R7aGal-3 transgene, which contains the albumin enhancer, is regulated in the same manner as that of the endogenous gene ( Fig. 7 and 8) , the enhancer region of the 7oa-hydroxylase gene, located 7 kb upstream of the transcriptional initiation site, does not seem to be involved in the regulation. Alternatively, similar interactions between the 7a-hydroxylase or the albumin enhancer with the 7a-hydroxylase promoter could be involved in the regulation. This is in agreement with the data that we obtain with tissue culture for the cholesterol-mediated regulation (Fig. 4) . It should be noted that albumin expression is not subject to cholesterol or bile acid regulation (Fig. 8) (16) , a finding which rules out the possibility that the observed regulation is mediated by the albumin enhancer. It is still possible that the regulation that we have observed is due to some fortuitous combination of sequences generated by the artificial albumin enhancer-7a-hydroxylase chimeric promoter or to the site of chromosomal integration. The fact that the regulation of the expression of the reporter gene parallels, almost identically, the regulation of the endogenous gene ( Fig. 7 and 8) by cholesterol, colestipol, and bile acids makes those possibilities very unlikely. Furthermore, preliminary experiments with a deleted version of the albumin enhancer-7a-hydroxylase promoter construct in transgenic mice (thus having different junction sequences) show similar expression of the reporter gene, ruling out the above-mentioned possibilities.
Surprisingly, the level of 3-galactosidase expression is between three-and fivefold higher in males than in females under all the dietary conditions tested (Fig. 7 and 8) , whereas the endogenous 7ox-hydroxylase gene is expressed at similar levels in mice (Fig. 8) or even in a reverse manner in rats (53) . There are two possible explanations for this observation. First, it is known that the place of chromosomal integration of the transgene plays a role in the level of its expression (42) . Perhaps the transgene was integrated in a locus that is transcribed at higher levels in males than in females. The other possible explanation is that the transgene is more methylated in female than in male mice and lower expression in females is a reflection of that. This phenomenon has been previously reported particularly in a C57BL/6 strain background. For example, Engler et al. (14) reported that a transgene [pHRD, containing target sequences for the V(D)J recombinase] was highly methylated in 12 independent mouse lines when introduced in a C57BL/6 strain background but became less methylated when bred into a DBAI2 background. Transgenes inherited from the mother are generally more methylated; however, this parental effect disappears following continued breeding into the nonmethylating strain. Swain et al. (54) have shown that a transgene containing both prokaryotic and eukaryotic DNA segments, none of which was derived from an authentically imprinted gene, was expressed exclusively from the paternal chromosome. The silent maternally inherited copies were highly methylated. Strain C57BL/6 is the origin of the mouse strain used in our experiments as an embryo donor and for mating of founder mice (see Materials and Methods). Experiments are in progress to assess these two possibilities.
Although there are several examples of genes whose transcription is down-regulated by cholesterol (20) and the DNA elements involved in that suppression have been defined (3, 40, 51) , no information on DNA element(s) responsible for bile acid-mediated regulation of gene transcription is available. The availability of these expression systems provides a novel and important step towards elucidating the molecular mechanisms involved in the regulation of 7ox-hydroxylase transcription by cholesterol and bile acids.
